What is the most recent earnings date for CSBR stock?
CHAMPIONS ONCOLOGY INC (CSBR) last reported earnings on 3/12/2026.
CHAMPIONS ONCOLOGY INC (CSBR) Earnings History & Surprises
NASDAQ:CSBR • US15870P3073
Current stock price
6.04 USD
+0.03 (+0.5%)
Last:
CSBR Earnings overview
Past quarterly earnings results for CHAMPIONS ONCOLOGY INC (CSBR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Jul 21, 2026
- Period
- Q4 / 2026
- EPS Estimate
- -$0.05
- Revenue Estimate
- 13.144M
Last Reported
Most Recent- Release Date
- Mar 12, 2026
- Period
- Q3 / 2026
- EPS Reported
- -$0.02
- EPS Surprise
- -121.79%
- Revenue Surprise
- -2.27%
Beat Rate
Last 8 Quarters 88%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2026 | -0.02 | 0.09 | -121.79% | -105.56% | 16.56M | 16.945M | -2.27% | -2.81% |
| Q2 2026 | 0.02 | 0.01 | 96.08% | -60.00% | 15.04M | 14.323M | 5.01% | 11.50% |
| Q1 2026 | 0.02 | -0.01 | 296.08% | -81.82% | 13.995M | 13.783M | 1.54% | -0.47% |
| Q4 2025 | -0.07 | -0.20 | 65.69% | -800.00% | 12.355M | 12.253M | 0.83% | -11.76% |
| Q3 2025 | 0.36 | -0.01 | 3,629.41% | 325.00% | 17.039M | 13.191M | 29.17% | 41.77% |
| Q2 2025 | 0.05 | 0.01 | 390.20% | 133.33% | 13.489M | 13.315M | 1.31% | 16.56% |
| Q1 2025 | 0.11 | -0.03 | 459.48% | 157.89% | 14.061M | 13.492M | 4.22% | 11.94% |
| Q4 2024 | 0.01 | -0.16 | 106.13% | 105.26% | 14.002M | 12.946M | 8.16% | 7.12% |
| Q3 2024 | -0.16 | -0.06 | -161.44% | 11.11% | 12.019M | 13.746M | -12.56% | -5.88% |
| Q2 2024 | -0.15 | -0.17 | 13.49% | - | 11.573M | 13.101M | -11.66% | -18.96% |
| Q1 2024 | -0.19 | -0.12 | -61.98% | -850.00% | 12.561M | 13.326M | -5.74% | -8.65% |
| Q4 2023 | -0.19 | -0.13 | -49.02% | -533.33% | 13.071M | 13.117M | -0.35% | 1.48% |
| Q3 2023 | -0.18 | -0.04 | -404.20% | -460.00% | 12.77M | 13.396M | -4.67% | -3.18% |
| Q2 2023 | 0.00 | -0.01 | 100.00% | -100.00% | 14.28M | 14.065M | 1.53% | 21.12% |
| Q1 2023 | -0.02 | 0.01 | -296.08% | -100.00% | 13.75M | 13.457M | 2.18% | 22.22% |
| Q4 2022 | -0.03 | 0.03 | -217.65% | 25.00% | 12.88M | 12.978M | -0.76% | 21.97% |
| Q3 2022 | 0.05 | 0.03 | 96.08% | - | 13.19M | 12.718M | 3.71% | 22.02% |
| Q2 2022 | 0.02 | 0.01 | 292.16% | - | 11.79M | 11.78M | 0.08% | 16.50% |
| Q1 2022 | -0.01 | 0.01 | -198.04% | -200.00% | 11.25M | 11.195M | 0.49% | 17.80% |
| Q4 2021 | -0.04 | 0.00 | - | 71.43% | 10.56M | 10.231M | 3.22% | 20.69% |
| Q3 2021 | 0.05 | 0.01 | 634.93% | 66.67% | 10.81M | 10.346M | 4.48% | 19.98% |
| Q2 2021 | 0.00 | 0.00 | - | -100.00% | 10.12M | 9.573M | 5.71% | 32.63% |
| Q1 2021 | 0.01 | 0.02 | -50.98% | 120.00% | 9.55M | 8.882M | 7.52% | 41.69% |
| Q4 2020 | -0.14 | 0.02 | -1,015.03% | - | 8.75M | 8.454M | 3.50% | - |
| Q3 2020 | 0.03 | 0.03 | 10.28% | - | 9.01M | 8.289M | 8.70% | - |
| Q2 2020 | 0.02 | 0.01 | 161.44% | - | 7.63M | 7.513M | 1.56% | - |
| Q1 2020 | -0.05 | 0.04 | -222.55% | - | 6.74M | 7.65M | -11.90% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
84.01%
Max EPS beat (4)
296.08%
Min EPS beat (4)
-121.79%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
1.28%
Max Revenue beat (4)
5.01%
Min Revenue beat (4)
-2.27%
Analysis
In the last 4 quarters, CSBR has beaten EPS estimates in 3 out of 4 releases
CSBR has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, CSBR has beaten the EPS estimates by 84.0% on average.
In the last 4 quarters, CSBR has beaten the revenue estimates by 1.3% on average.
Related analysis
CHAMPIONS ONCOLOGY INC / CSBR Earnings FAQ
Did CHAMPIONS ONCOLOGY INC (CSBR) beat earnings estimates last quarter?
CHAMPIONS ONCOLOGY INC (CSBR) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does CHAMPIONS ONCOLOGY INC (CSBR) beat earnings estimates?
In the last 4 quarters, CHAMPIONS ONCOLOGY INC (CSBR) has beaten EPS estimates in 3 out of 4 releases.